Evidence map›Paper›PMID 40819933›Full record

ReviewInternational journal of laboratory hematology2025

Breaking Free From MCHC Interferences? French-Speaking Cellular Haematology Group (GFHC) Review of Causes, Rising Trends and Practical Solutions.

Sandrine Girard, Yaël Berda-Haddad, Chantal Brouzes, Bouchra Badaoui, Agathe Boussaroque, Alexandre Janel, Bernard Chatelain, Véronique Baccini

Abstract readReview
In one paragraph

Review in International journal of laboratory hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sandrine GirardHaematology Biology, Hospices Civils de Lyon, Lyon, France.
Yaël Berda-HaddadHaematology Biology, University Hospital Timone, AP-HM, Marseille, France.
Chantal BrouzesHaematology Biology, AP-HP Hospital Necker, France.
Bouchra BadaouiHaematology Biology, AP-HP Hospital Henri Mondor, France.
Agathe BoussaroqueHaematology Biology, University Hospital, Angers, France.
Alexandre JanelHaematology Biology, INOVIE GENBIO, Clermont-Ferrand, France.
Bernard ChatelainHaematology Biology, CHU UCL Namur, Yvoir, Belgium.
Véronique BacciniHaematology Biology, University Hospital Guadeloupe, Pointe-à-Pitre, Université Paris Cité, France.ORCID https://orcid.org/0000-0003-3913-7664

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mean corpuscular haemoglobin concentration (MCHC) is determined by the ratio of haemoglobin concentration to haematocrit. Managing increased MCHC presents significant challenges, mainly due to variations in analytical methods and pathophysiological conditions. Depending on the haematological analyser (HA), MCHC can be measured directly or calculated. It is important that all people involved in hematocytometry must identify and correct artefacts to ensure accurate erythrocyte parameters. In order to harmonise and standardise haematology practices in all laboratories, the French-speaking Cellular Haematology Group (GFHC) has reviewed the interferences and pathophysiological situations that could increase MCHC, and the advice on how to manage cases of elevated MCHC. We will review current techniques, such as impedance and optical methods, for accurate determination of MCHC. We will also examine the interferences that can artificially increase MCHC; and the pathophysiological conditions responsible for such increases. Finally, we will present guidelines for the management of elevated MCHC, including strategies to bypass interferences and determine which erythrocyte parameters can be reliably reported, as well as the acceptable MCHC values for various pathophysiological variations.

Indexed as

Erythrocyte IndicesHematologic TestsHematologyErythrocytesFranceHumansdecision treesGFHCinterferencesMCHCrecommendations

Identifiers

PMID40819933
PMCPMC12426809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.